Brief: Victory Square Technologies Says Receives Approval For Sale And Use Of Covid-19 Antibody Test For EU
14/09/2020 08:07
Sept 14 (Reuters) - Victory Square Technologies Inc
VST.CD :
* VICTORY SQUARE TECHNOLOGIES PORTFOLIO COMPANY RECEIVES
APPROVAL
FOR SALE AND USE OF SAFETEST COVID-19 ANTIBODY TEST FOR THE
EUROPEAN UNION
* VICTORY SQUARE TECHNOLOGIES INC - GRANTED EU DECLARATION
OF
CONFORMITY
* VICTORY SQUARE- CE DESIGNATION ALLOWS CO TO COMMENCE
MARKETING,
SALES& DISTRIBUTION FOR ELISA COVID-19 ASSAY UNTIL MAY 2022
Source text for Eikon: ID:nGNX3MlySX
Further company coverage: VST.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Victory Square Technologies
See all newsCanada's Victory Square Q2 revenue jumps on Hydreight strength
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Technologies Declares Special Common Share Dividend Of Its Interest In Yocale.ai
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent